… We considered only the event first experienced by the patient, so that the patients who had
persistent PTC were not considered at risk of recurrence. Only PTC followed for at least 1 …

… Consequently, the major clinical challenge is to stratify patients by risk of mortality or
recurrence. At present, several clinicopathologic characteristics have been recognized as being …

… a higher risk of recurrence.7–10 It is well established that in patients with local recurrence,
surgery remains the first line of treatment but is associated with a higher risk of complications. …

… thyroid hormone suppression are most appropriate for the majority of patients with … thyroid
cancer, as retrospective analyses have shown that they reduce the risk of cancer recurrence, …

… thyroid cancer at intermediate or high risk of recurrence after RAI therapy; we excluded studies
on low-risk patients only and we excluded the low-risk … intermediate/high-risk patients [1]. …

… thyroid disease, including thyroid cancer. In our reports the mortality rate in young patients
with differentiated thyroid cancer dropped from 7% to 1%, and the recurrence … both recurrence …

… study estimated that 5840 patients in a prospective, randomized, controlled trial would be
necessary to have sufficient statistical power to detect a 25% reduction in the recurrence risk.…

… Optimal management of thyroid cancer requires a risk adapted approach in which the
intensity of therapy and follow-up is tailored to individualized risks of recurrence and disease-…

… Our findings suggest that R1 resection of involved organs is predictive of increased risk of
LRR, and total recurrence including distant metastasis in locally advanced DTC. This likely to …

… In almost all cases, these thyroid cancer recurrences arise … thyroid gland tissue, fails to
identify residual thyroid cancer in a … Recurrence (presence of residual disease) risk increases as …